{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:24:24Z","timestamp":1777940664961,"version":"3.51.4"},"reference-count":51,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Royal College of Physicians of Edinburgh"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Venous thromboembolism (VTE) is frequently encountered across various specialties. The management of VTE has become more nuanced, requiring consideration of several factors when deciding on the choice and duration of anticoagulation. This evidence-based review article summarises the current practice and evidence behind anticoagulation in VTE, incorporating national and international guidelines. Factors influencing decision-making around the choice and duration of anticoagulation, along with special circumstances such as cancer and antiphospholipid syndrome, are discussed. The clinical utility of thrombophilia screening is also addressed.<\/jats:p>","DOI":"10.1177\/14782715241241834","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:10:00Z","timestamp":1711671000000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation in venous thromboembolism for the general physician"],"prefix":"10.1177","volume":"54","author":[{"given":"Katherine","family":"Stark","sequence":"first","affiliation":[{"name":"Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, NHS Grampian, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, NHS Grampian, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, NHS Grampian, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"bibr1-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00787-6"},{"key":"bibr2-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1159\/000083844"},{"key":"bibr3-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.02.015"},{"key":"bibr4-14782715241241834","volume":"109","author":"Lecumberri R","year":"2013","journal-title":"Thromb Haemost"},{"key":"bibr5-14782715241241834","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1094"},{"key":"bibr6-14782715241241834","unstructured":"NICE. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline [NG158], https:\/\/www.nice.org.uk\/guidance\/ng158 (2023, accessed 9 December 2023)."},{"key":"bibr7-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18239"},{"key":"bibr8-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830"},{"key":"bibr9-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010177"},{"key":"bibr10-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16308"},{"key":"bibr11-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09037.x"},{"key":"bibr12-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211646"},{"key":"bibr13-14782715241241834","volume":"2020","author":"Chiasakul T","year":"2020","journal-title":"Hematology ASH Education Program"},{"key":"bibr14-14782715241241834","volume":"2020","author":"Kelkar AH","year":"2020","journal-title":"Hematology ASH Education Program"},{"key":"bibr15-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13299"},{"key":"bibr16-14782715241241834","volume":"359","author":"L\u00f3pez-L\u00f3pez JA","year":"2017","journal-title":"BMJ (Online)"},{"key":"bibr17-14782715241241834","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0511"},{"key":"bibr18-14782715241241834","first-page":"279","volume":"149","author":"Joosten LPT","year":"2023","journal-title":"Circulation (New York, N.Y.)"},{"key":"bibr19-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102240"},{"key":"bibr20-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18903"},{"key":"bibr21-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01413-x"},{"key":"bibr22-14782715241241834","volume":"138","author":"Siontis KC","year":"2018","journal-title":"Circulation (New York, N.Y.)"},{"key":"bibr23-14782715241241834","volume":"22","author":"Jones A","year":"2023","journal-title":"J Thromb Haemost"},{"key":"bibr24-14782715241241834","volume":"2021","author":"Roberts LN.","year":"2021","journal-title":"Hematology ASH Educ Program"},{"key":"bibr25-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-021-00482-w"},{"key":"bibr26-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15358"},{"key":"bibr27-14782715241241834","volume":"2020","author":"\u00c1inle FN","year":"2020","journal-title":"Hematology ASH Educ Program"},{"key":"bibr28-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102274"},{"key":"bibr29-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13336"},{"key":"bibr30-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.367"},{"key":"bibr31-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03991.x"},{"key":"bibr32-14782715241241834","volume":"362","author":"Baglin T","year":"2003","journal-title":"Lancet (British ed.)"},{"key":"bibr33-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1065"},{"key":"bibr34-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04735.x"},{"key":"bibr35-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13781"},{"key":"bibr36-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad618"},{"key":"bibr37-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.02.001"},{"key":"bibr38-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00077-2018"},{"key":"bibr39-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03055.x"},{"key":"bibr40-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18276"},{"key":"bibr41-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025313"},{"key":"bibr42-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.10.041"},{"key":"bibr43-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01289-1"},{"key":"bibr44-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13556"},{"key":"bibr45-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14015"},{"key":"bibr46-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22066"},{"key":"bibr47-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.04.009"},{"key":"bibr48-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333"},{"key":"bibr49-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15158"},{"key":"bibr50-14782715241241834","unstructured":"Gov.uk. Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome, https:\/\/www.gov.uk\/drug-safety-update\/direct-acting-oral-anticoagulants-doacs-increased-risk-of-recurrent-thrombotic-events-in-patients-with-antiphospholipid-syndrome (2019, accessed 16 December 2023)."},{"key":"bibr51-14782715241241834","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005808"}],"container-title":["Journal of the Royal College of Physicians of Edinburgh"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14782715241241834","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14782715241241834","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14782715241241834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:57:02Z","timestamp":1777701422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14782715241241834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1177\/14782715241241834"],"URL":"https:\/\/doi.org\/10.1177\/14782715241241834","relation":{},"ISSN":["1478-2715","2042-8189"],"issn-type":[{"value":"1478-2715","type":"print"},{"value":"2042-8189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}